Stocks on the Move: TPIV, INO, MBCI, CRXL

	Search News Daily News

NEWS

Daily News Top Stories Breaking News World Politics Business Growth Minute Health Breast Cancer Food & Wine Women Women in Business Opinion Letters to the Editor High Tech Sports Horoscope Entertainment Entertainment Goss Music Features Books Poetry Movie Reviews Home & Garden Industry States Health Column Senior Health Environment Education SupportOurTroops Middle East South Asia Cartoons Video Releases Most Read

WIRES

Eworldwire Marketwire GlobeNewswire PRNewswire Send2Press Marketwire Canada 24-7 Pressrelease Realwire PR.com ACNNewswire Business Wire NewsBlazeWire Spanish Releases Movers/Shakers

OTHER

About Us Contact Us Feedback Writers Bookmarks Link to Us Advertise Sitemap

TECHNOLOGY

RFID Supply Chain Text to Speech Voice Over IP Wi-Fi Games iPod Biotech

NEWSPAPERS

Folsom Orange County Boca Raton St Augustine Vero Beach

Breaking News: Tea Party Against Reid Health Care Bill

Published:

Send to a friend

Stocks on the Move: TPIV, INO, MBCI, CRXL

TapImmune Inc. (OTCBB: TPIV), a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases, has signed a license agreement with Crucell N.V (NASDAQ: CRXL).

Terms of the agreement allow TapImmune to use the proprietary PER.C6® cells in its development programs. The PER.C6® cell line is suited for the development and large-scale manufacturing of a multitude of biopharmaceuticals. In the use of recombinant vaccines using adenoviral vectors, PER.C6® cells do not generate replication competent adenoviruses, making it the state-of-the-art platform for the large-scale production of adenoviral vectors for clinical applications.

Inovio Biomedical Corporation (AMEX: INO) engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines rose almost 4% for the week.

Yesterday, MabCure N.V, a subsidiary of MabCure Inc. (OTCBB: MBCI), announced the signing of a research agreement with AZ Sint Lucas Hospital, Brugge, Belgium, to conduct preclinical research on its Monoclonal Antibodies (Mabs) against different cancers.

About Smallcap-Investors.com

Smallcap-Investors.com.com is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. Smallcap-Investors goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Smallcap-Investors.com offers a free financial newsletter. To subscribe or get more information, visit our home page located at www.Smallcap-Investors.com. An affiliate of Smallcap-Investors.com has been promised compensation by TapImmune Inc. for the dissemination of this Press Release.

Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze, Daily News

Tags: ,FinancialServices:InvestmentOpinion, ,AMEX0001,NASDAQ01,OTCBULLB,OTCBULLB,NASDAQ01,AMEX0001,OTCBULLB,FL,BOCA RATON, FL

Be Interviewed today

Editorial Cartoons
Political Cartoons

<style> /* RESET STYLES */ .fxw hr,.fxw div,.fxw span,.fxw h1,.fxw h2,.fxw h3,.fxw p,.fxw a,.fxw em,.fxw img,.fxw strong,.fxw ol,.fxw ul,.fxw li {margin: 0;padding: 0;border: 0;outline: 0;font-weight: inherit;font-style: inherit;font-size: 100%;font-family: inherit;vertical-align: baseline;line-height: 1;list-style: none; } .fxw {font-family: Arial, sans-serif !important;font-size: 11px !important;border: 1px solid #004c00;background-color: #fff;position: relative !important;} .fxw .clear {clear: both !important;height: 1px !important;overflow: hidden !important; } /* Header */ .fxw_header {color: #fff;background: #004c00;padding: 10px !important;font-weight: bold !important;font-size: 14px !important;} /* Footer */ .fxw_footer {color: #fff;background: #004c00;padding: 10px !important;} .fxw_footer a{text-decoration: none !important;font-weight: bold !important;color: #fff;} .fxw_footer .fxw_pipe {padding: 0px 3px 0px 3px;} /* Body */ .fxw_body {padding: 10px !important;overflow: auto !important; } /* Story Item */ .fxw_story {border-bottom: 1px solid #e3e3e3 !important;padding-bottom: 8px !important;margin-bottom: 8px !important;} .fxw_story.fxw_last {border: 0px !important;} .fxw_story.fxw_image {padding-left: 60px !important;} .fxw_story.fxw_image img {float: left;width: 50px;margin: 0px 0px 0px -60px;} /* Story Title */ .fxw_title {margin: 0px !important;padding: 0px !important;} .fxw_title a {text-decoration: none !important;font-weight: bold !important;font-size: 12px !important;line-height: 16px !important;color: #000099; } /* Story Description */ .fxw_desc {color: #666;padding: 0px !important;margin: 1px 0px 0px 0px !important;line-height: 14px !important;font-size: 11px !important;} /* Story Image */ img.fxw_image {width: 35px !important;height: 35px !important;margin: 2px 0px 0px -45px !important;float: left !important;} </style> <script type="text/javascript"> fxw_city = ''; fxw_limit = 6; fxw_source = ''; fxw_topic = ''; fxw_id = 'fxw_container'; fxw_target = '_blank'; fxw_showImage = false; fxw_showDescription = false; fxw_customCSS = true; </script> <script type="text/javascript" src="http://fwix.com/tools/widget/v1"></script> <a href="http://fwix.com" id="fxw_clear"><img src="http://fwix.com/images/clear.gif" border="0" title="Fwix - Your New Local Newspaper" /></a>

NewsBlaze on Twitter
NewsBlaze on Facebook
NewsBlaze on MySpace

Sponsor Links:

Writers Wanted

Help NewsBlaze provide daily news, including top stories, Home and Garden, Technology, The Environment and more. NewsBlaze Writer

Relevant Sites:

NewsBlaze

Copyright © 2004-2009 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy Support Press Room